secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kalaris Therapeutics, Inc. (KLRS)
CIK:        0001754068
Form:       8-K
Filed at:   2023-06-26T23:59:59+00:00
Accession:  0001193125-23-175095
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AlloVir prices public offering of 20M shares at $3.75/share for $75M gross
--------------------------------------------------------------------------

- Priced underwritten public offering of 20,000,000 shares at $3.75 per share; gross proceeds of $75.0M.
- Net proceeds estimated at $70.2M ($80.7M if underwriters fully exercise 30-day option for 3M additional shares).
- Offering expected to close on or about June 26, 2023; underwriters include J.P. Morgan, Morgan Stanley, and BofA.
- Shares offered under existing shelf registration; 90-day lock-up for AlloVir executives and directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1754068/000119312523175095/0001193125-23-175095-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1754068/000119312523175095/d472315d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-175095

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer